These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17402728)

  • 1. The first ruthenium-based paullones: syntheses, X-ray diffraction structures, and spectroscopic and antiproliferative properties in vitro.
    Schmid WF; Zorbas-Seifried S; John RO; Arion VB; Jakupec MA; Roller A; Galanski MS; Chiorescu I; Zorbas H; Keppler BK
    Inorg Chem; 2007 Apr; 46(9):3645-56. PubMed ID: 17402728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic insights into the chemistry of RuII complexes containing Cl and DMSO ligands.
    Mola J; Romero I; Rodríguez M; Bozoglian F; Poater A; Solà M; Parella T; Benet-Buchholz J; Fontrodona X; Llobet A
    Inorg Chem; 2007 Dec; 46(25):10707-16. PubMed ID: 18001116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of organoruthenium(II) 3-(1H-benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and indolo[3,2-d]benzazepines to recombinant human serum albumin: a strategy to enhance cytotoxicity in cancer cells.
    Stepanenko IN; Casini A; Edafe F; Novak MS; Arion VB; Dyson PJ; Jakupec MA; Keppler BK
    Inorg Chem; 2011 Dec; 50(24):12669-79. PubMed ID: 22111668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly cytotoxic copper(II) complexes with modified paullone ligands.
    Primik MF; Mühlgassner G; Jakupec MA; Zava O; Dyson PJ; Arion VB; Keppler BK
    Inorg Chem; 2010 Jan; 49(1):302-11. PubMed ID: 19968251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuning of redox properties for the design of ruthenium anticancer drugs: part 2. Syntheses, crystal structures, and electrochemistry of potentially antitumor [Ru III/II Cl6-n(Azole)n]z(n = 3, 4, 6) complexes.
    Reisner E; Arion VB; Eichinger A; Kandler N; Giester G; Pombeiro AJ; Keppler BK
    Inorg Chem; 2005 Sep; 44(19):6704-16. PubMed ID: 16156629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the piperazine unit and metal-binding site position on the solubility and anti-proliferative activity of ruthenium(II)- and osmium(II)- arene complexes of isomeric indolo[3,2-c]quinoline-piperazine hybrids.
    Filak LK; Kalinowski DS; Bauer TJ; Richardson DR; Arion VB
    Inorg Chem; 2014 Jul; 53(13):6934-43. PubMed ID: 24927493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
    Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
    Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isomeric [RuCl2(dmso)2(indazole)2] complexes: ruthenium(II)-mediated coupling reaction of acetonitrile with 1H-indazole.
    Reisner E; Arion VB; Rufińska A; Chiorescu I; Schmid WF; Keppler BK
    Dalton Trans; 2005 Jul; (14):2355-64. PubMed ID: 15995743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
    Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
    Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium- and Osmium-Arene Complexes of 2-Substituted Indolo[3,2-c]quinolines: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity.
    Filak LK; Mühlgassner G; Bacher F; Roller A; Galanski M; Jakupec MA; Keppler BK; Arion VB
    Organometallics; 2011 Jan; 30(2):273-283. PubMed ID: 21253447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium-nitrosyl complexes with glycine, L-alanine, L-valine, L-proline, D-proline, L-serine, L-threonine, and L-tyrosine: synthesis, X-ray diffraction structures, spectroscopic and electrochemical properties, and antiproliferative activity.
    Rathgeb A; Böhm A; Novak MS; Gavriluta A; Dömötör O; Tommasino JB; Enyedy EA; Shova S; Meier S; Jakupec MA; Luneau D; Arion VB
    Inorg Chem; 2014 Mar; 53(5):2718-29. PubMed ID: 24555845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of Structure-Activity Relationships in Indolobenzazepine-Derived Ligands and Their Copper(II) Complexes: the Role of Key Structural Components and Insight into the Mechanism of Action.
    Kuznetcova I; Bacher F; Alfadul SM; Tham MJR; Ang WH; Babak MV; Rapta P; Arion VB
    Inorg Chem; 2022 Jul; 61(26):10167-10181. PubMed ID: 35713376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2].
    Büchel GE; Stepanenko IN; Hejl M; Jakupec MA; Keppler BK; Arion VB
    Inorg Chem; 2011 Aug; 50(16):7690-7. PubMed ID: 21739939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization and DNA binding studies of two mixed ligand complexes of ruthenium(II).
    Lawrence D; Vaidyanathan VG; Nair BU
    J Inorg Biochem; 2006 Jul; 100(7):1244-51. PubMed ID: 16554091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-cis-cis-[RuCl2(DMSO)2(2-amino-5-methyl-thiazole)2], (PMRu52), a novel ruthenium(II) compound acting as a strong inhibitor of cathepsin B.
    Mura P; Camalli M; Casini A; Gabbiani C; Messori L
    J Inorg Biochem; 2010 Feb; 104(2):111-7. PubMed ID: 19939460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of water-soluble, heteronuclear ruthenium(III)/ferrocene complexes and their interactions with biomolecules.
    Anderson CM; Jain SS; Silber L; Chen K; Guha S; Zhang W; McLaughlin EC; Hu Y; Tanski JM
    J Inorg Biochem; 2015 Apr; 145():41-50. PubMed ID: 25621836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osmium NAMI-A analogues: synthesis, structural and spectroscopic characterization, and antiproliferative properties.
    Cebrián-Losantos B; Krokhin AA; Stepanenko IN; Eichinger R; Jakupec MA; Arion VB; Keppler BK
    Inorg Chem; 2007 Jun; 46(12):5023-33. PubMed ID: 17497853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates.
    Riedl CA; Flocke LS; Hejl M; Roller A; Klose MH; Jakupec MA; Kandioller W; Keppler BK
    Inorg Chem; 2017 Jan; 56(1):528-541. PubMed ID: 27996251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, in vitro antitumor activity, DNA-binding properties and electronic structure (DFT) of the new complex cis-(Cl,Cl)[RuIICl2(NO+)(terpy)]Cl.
    Karidi K; Garoufis A; Tsipis A; Hadjiliadis N; den Dulk H; Reedijk J
    Dalton Trans; 2005 Apr; (7):1176-87. PubMed ID: 15782252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.
    Schmid WF; John RO; Mühlgassner G; Heffeter P; Jakupec MA; Galanski MS; Berger W; Arion VB; Keppler BK
    J Med Chem; 2007 Dec; 50(25):6343-55. PubMed ID: 17997519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.